Marketing-authorisation holder · Canada
Takeda Canada Inc
138 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
138 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 138
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADDERALL XR10 mg · Capsule (Extended-Release) | Amfetamine | Canada | Marketed | 2004 |
| ADDERALL XR5 mg · Capsule (Extended-Release) | Amfetamine | Canada | Marketed | 2004 |
| ADDERALL XR20 mg · Capsule (Extended-Release) | Amfetamine | Canada | Marketed | 2004 |
| ADDERALL XR15 mg · Capsule (Extended-Release) | Amfetamine | Canada | Marketed | 2004 |
| ADDERALL XR25 mg · Capsule (Extended-Release) | Amfetamine | Canada | Marketed | 2004 |
| ADDERALL XR30 mg · Capsule (Extended-Release) | Amfetamine | Canada | Marketed | 2004 |
| ADVATE1500 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE3000 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Not marketed | 2010 |
| ADVATE3000 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE1000 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE250 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE2000 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE1500 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE250 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Not marketed | 2012 |
| ADVATE1000 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE1000 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE1500 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE2000 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Not marketed | 2008 |
| ADVATE1000 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Not marketed | 2006 |
| ADVATE500 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Authorised | |
| ADVATE500 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Not marketed | 2012 |
| ADVATE1500 unit / vial · Powder For Solution | Antihemophilic factor | Canada | Not marketed | 2006 |
| ADYNOVATE2000 unit / vial · Kit, Powder For Solution | Antihemophilic factor | Canada | Marketed | 2018 |
| ADYNOVATE250 unit / vial · Kit, Powder For Solution | Antihemophilic factor | Canada | Marketed | 2021 |
| ADYNOVATE1000 unit / vial · Kit, Powder For Solution | Antihemophilic factor | Canada | Marketed | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 138 | 113 | 25 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.